+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Untargeted Metabolomics Market - Global Forecast 2026-2032- Product Image
Untargeted Metabolomics Market - Global Forecast 2026-2032- Product Image
Sale

Untargeted Metabolomics Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6150079
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Untargeted Metabolomics Market is projected to reach USD 598.99 Million in 2026. It is expected to continue growing at a CAGR of 10.59%, reaching USD 1.09 Billion by 2032.

Untargeted Metabolomics: Executive Overview

Untargeted metabolomics uses high-resolution analytical platforms to profile as many measurable metabolites as possible without restricting analysis to a predefined compound list. The approach supports discovery of biomarkers, biological pathways, disease mechanisms, and treatment-response signals across research, translational science, food, environmental, and industrial applications. Its value depends on robust sample handling, analytical quality control, spectral annotation, statistical validation, and biological interpretation.

How Untargeted Metabolomics Is Transforming Research

The field is shifting from isolated analytical experiments toward integrated, standardized, and longitudinal studies. Improvements in mass spectrometry, nuclear magnetic resonance, chromatography, reference libraries, and quality-control practices are strengthening reproducibility and expanding coverage. Researchers are also combining metabolomics with genomics, transcriptomics, proteomics, imaging, and clinical data to connect molecular patterns with phenotypes and outcomes. Persistent challenges include incomplete metabolite identification, batch effects, matrix complexity, interoperability, and the need for independent validation.

Artificial Intelligence Accelerates Annotation and Interpretation

Artificial intelligence and machine learning are increasingly applied to spectral feature detection, peak alignment, metabolite annotation, missing-data handling, dimensionality reduction, biomarker prioritization, and pathway interpretation. These tools can reduce manual review and identify nonlinear relationships that conventional workflows may overlook. Their reliability depends on representative training data, transparent model evaluation, external validation, and careful control of confounding. Human expertise remains essential because predicted compound identities and biological associations require experimental confirmation.

Regional Insights Across the Global Research Ecosystem

North America combines advanced biomedical research infrastructure, established clinical networks, and strong adoption of high-resolution analytical methods. Europe benefits from coordinated research programs, sophisticated biobanks, and regulatory attention to data quality and reproducibility. Asia-Pacific is supported by expanding life-science capacity, substantial population diversity, and growing investment in analytical technologies. Latin America is developing capabilities through academic and clinical collaborations, although access to instrumentation, standardized reference materials, and specialist training varies. The Middle East is building research capacity through healthcare modernization and institutional investment, while Africa presents important opportunities for population-relevant metabolomics alongside continuing constraints in infrastructure, sample logistics, and data resources.

Group Insights: Multilateral and Regional Blocs

ASEAN countries can benefit from shared protocols and cross-border studies that reflect diverse diets, environments, and disease burdens. BRICS collaboration can broaden access to complementary cohorts, analytical facilities, and computational expertise, while requiring careful harmonization of governance and laboratory standards. The European Union’s coordinated research environment supports multicenter studies and data interoperability. G7 members contribute substantial capabilities in clinical translation, instrumentation, and methodological development. GCC countries are positioned to apply metabolomics to metabolic health, precision medicine, and environmental research through centralized infrastructure. NATO members can strengthen interoperability, biosafety, and emergency-response research while maintaining clear civilian scientific governance.

Country Insights: Capabilities and Application Priorities

Australia can apply untargeted metabolomics to population health, agriculture, marine systems, and geographically diverse cohorts. Brazil offers strong relevance for biodiversity, nutrition, infectious disease, and agricultural research. Canada brings expertise in biobanking, environmental science, and precision health. China is expanding broad analytical and translational research capacity, while India can address substantial diversity in nutrition, chronic disease, and infectious conditions. Japan and South Korea combine advanced instrumentation with strong biomedical and industrial research traditions. France, Germany, Italy, Spain, and the United Kingdom support substantial academic, clinical, and pharmaceutical research networks, with emphasis on reproducibility and translational validation. Mexico can extend applications in public health, agriculture, and environmental monitoring. Russia retains relevant capabilities in analytical and biomedical science, with collaboration shaped by access, governance, and infrastructure considerations. The United States remains a major center for platform development, clinical research, and computational integration.

Priorities for Industry and Research Leaders

Leaders should establish end-to-end quality systems covering collection, storage, extraction, instrument calibration, pooled controls, blanks, reference materials, and batch correction. They should define identification confidence levels before analysis, preserve raw and processed data, and preregister key validation criteria where appropriate. Investments should prioritize interoperable data architectures, curated spectral libraries, staff training, and independent replication rather than isolated instrument acquisition. Organizations should also assess AI models for bias, drift, explainability, and external performance, and build partnerships linking analytical laboratories with clinicians, biologists, statisticians, and domain specialists.

Research Methodology for the Executive Summary

This summary is based on the supplied market topic and the required geographic and group frameworks. It uses established characteristics of untargeted metabolomics, including analytical workflows, applications, enabling technologies, infrastructure needs, and research-governance considerations. Regional, group, and country observations are presented as qualitative context rather than numerical market claims. No estimates, forecasts, market shares, or company-specific assessments are included. Interpretation should be supplemented with current primary literature, regulatory materials, laboratory-performance data, and locally validated evidence before strategic decisions are made.

Conclusion: Building Reliable Discovery-to-Translation Pathways

Untargeted metabolomics is becoming more valuable as analytical sensitivity, computational interpretation, and multi-omics integration improve. The strongest outcomes will come from disciplined experimental design, transparent annotation, standardized quality control, and validation in independent cohorts or systems. Regional collaboration can broaden biological relevance, while responsible AI can improve scale and prioritization without replacing scientific judgment. Organizations that connect robust measurement with clear biological questions and reproducible data practices will be best positioned to translate metabolomic discovery into useful research and applied outcomes.

This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Untargeted Metabolomics Market, by Component
7.1. Introduction
7.2. Consumables And Accessories
7.3. Instruments
7.3.1. Chromatography Instruments
7.3.2. Mass Spectrometry Instruments
7.4. Software And Services
8. Untargeted Metabolomics Market, by Technology
8.1. Introduction
8.2. Ce-Ms
8.3. Gc-Ms
8.4. Lc-Ms
8.5. Nmr
9. Untargeted Metabolomics Market, by Sample Type
9.1. Introduction
9.2. Cell Culture
9.3. Plasma And Serum
9.4. Tissue
9.5. Urine
10. Untargeted Metabolomics Market, by Application
10.1. Introduction
10.2. Biomarker Discovery
10.3. Drug Discovery
10.4. Metabolic Profiling
10.5. Nutritional Research
11. Untargeted Metabolomics Market, by End User
11.1. Introduction
11.2. Academic And Government
11.3. Clinical Diagnostics
11.4. Food And Beverage
11.5. Pharmaceutical And Biotechnology
12. Untargeted Metabolomics Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Untargeted Metabolomics Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Untargeted Metabolomics Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. Agilent Technologies Inc.
16.2. Bio-Rad Laboratories, Inc.
16.3. Biocrates Life Sciences AG
16.4. Bruker Corporation
16.5. Danaher Corporation
16.6. LECO Corporation
16.7. Metabolon, Inc.
16.8. PerkinElmer, Inc.
16.9. Shimadzu Corporation
16.10. Thermo Fisher Scientific Inc.
16.11. Waters Corporation
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Untargeted Metabolomics Market, Years Considered for the Study
FIGURE 2. Global Untargeted Metabolomics Market, Research Design
FIGURE 3. Global Untargeted Metabolomics Market, Research Framework
FIGURE 4. Global Untargeted Metabolomics Market, Data Triangulation
FIGURE 5. Global Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Untargeted Metabolomics Market Size, by Component, 2025 vs 2032 (%)
FIGURE 7. Global Untargeted Metabolomics Market Size, by Component, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Untargeted Metabolomics Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Untargeted Metabolomics Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Untargeted Metabolomics Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Untargeted Metabolomics Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Untargeted Metabolomics Market Size, by Application, 2025 vs 2032 (%)
FIGURE 13. Global Untargeted Metabolomics Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Untargeted Metabolomics Market Size, by End User, 2025 vs 2032 (%)
FIGURE 15. Global Untargeted Metabolomics Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Untargeted Metabolomics Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Untargeted Metabolomics Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Untargeted Metabolomics Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Untargeted Metabolomics Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Untargeted Metabolomics Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Untargeted Metabolomics Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Untargeted Metabolomics Market Segmentation & Coverage
TABLE 2. Global Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 3. Global Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 4. Global Consumables And Accessories Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Consumables And Accessories Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Consumables And Accessories Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Chromatography Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Chromatography Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Chromatography Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Mass Spectrometry Instruments Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Mass Spectrometry Instruments Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Mass Spectrometry Instruments Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Software And Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Software And Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Software And Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 20. Global Ce-Ms Market Size, by Region, 2017-2032 (USD Million)
TABLE 21. Global Ce-Ms Market Size, by Group, 2017-2032 (USD Million)
TABLE 22. Global Ce-Ms Market Size, by Country, 2017-2032 (USD Million)
TABLE 23. Global Gc-Ms Market Size, by Region, 2017-2032 (USD Million)
TABLE 24. Global Gc-Ms Market Size, by Group, 2017-2032 (USD Million)
TABLE 25. Global Gc-Ms Market Size, by Country, 2017-2032 (USD Million)
TABLE 26. Global Lc-Ms Market Size, by Region, 2017-2032 (USD Million)
TABLE 27. Global Lc-Ms Market Size, by Group, 2017-2032 (USD Million)
TABLE 28. Global Lc-Ms Market Size, by Country, 2017-2032 (USD Million)
TABLE 29. Global Nmr Market Size, by Region, 2017-2032 (USD Million)
TABLE 30. Global Nmr Market Size, by Group, 2017-2032 (USD Million)
TABLE 31. Global Nmr Market Size, by Country, 2017-2032 (USD Million)
TABLE 32. Global Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 33. Global Cell Culture Market Size, by Region, 2017-2032 (USD Million)
TABLE 34. Global Cell Culture Market Size, by Group, 2017-2032 (USD Million)
TABLE 35. Global Cell Culture Market Size, by Country, 2017-2032 (USD Million)
TABLE 36. Global Plasma And Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 37. Global Plasma And Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 38. Global Plasma And Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 39. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 40. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 41. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 42. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 43. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 44. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 45. Global Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 46. Global Biomarker Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Biomarker Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Biomarker Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Drug Discovery Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Drug Discovery Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Drug Discovery Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Metabolic Profiling Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Metabolic Profiling Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Metabolic Profiling Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Nutritional Research Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Nutritional Research Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Nutritional Research Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 59. Global Academic And Government Market Size, by Region, 2017-2032 (USD Million)
TABLE 60. Global Academic And Government Market Size, by Group, 2017-2032 (USD Million)
TABLE 61. Global Academic And Government Market Size, by Country, 2017-2032 (USD Million)
TABLE 62. Global Clinical Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Clinical Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Clinical Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Food And Beverage Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Food And Beverage Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Food And Beverage Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Pharmaceutical And Biotechnology Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Pharmaceutical And Biotechnology Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Pharmaceutical And Biotechnology Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Untargeted Metabolomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Asia-Pacific Untargeted Metabolomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Asia-Pacific Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 74. Asia-Pacific Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 75. Asia-Pacific Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 76. Asia-Pacific Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 77. Asia-Pacific Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 78. Asia-Pacific Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. North America Untargeted Metabolomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. North America Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 81. North America Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 82. North America Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 83. North America Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 84. North America Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 85. North America Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 86. Latin America Untargeted Metabolomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Latin America Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 88. Latin America Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 89. Latin America Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 90. Latin America Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 91. Latin America Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 92. Latin America Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 93. Europe Untargeted Metabolomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 94. Europe Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 95. Europe Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 96. Europe Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 97. Europe Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 98. Europe Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 99. Europe Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 100. Middle East Untargeted Metabolomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 101. Middle East Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 102. Middle East Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 103. Middle East Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 104. Middle East Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 105. Middle East Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 106. Middle East Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 107. Africa Untargeted Metabolomics Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Africa Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 109. Africa Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 110. Africa Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 111. Africa Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 112. Africa Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 113. Africa Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 114. Global Untargeted Metabolomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. ASEAN Untargeted Metabolomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. ASEAN Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 117. ASEAN Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 118. ASEAN Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 119. ASEAN Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 120. ASEAN Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 121. ASEAN Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 122. GCC Untargeted Metabolomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 123. GCC Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 124. GCC Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 125. GCC Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 126. GCC Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 127. GCC Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 128. GCC Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. European Union Untargeted Metabolomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 130. European Union Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 131. European Union Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 132. European Union Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 133. European Union Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 134. European Union Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 135. European Union Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 136. BRICS Untargeted Metabolomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. BRICS Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 138. BRICS Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 139. BRICS Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 140. BRICS Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 141. BRICS Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 142. BRICS Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 143. G7 Untargeted Metabolomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. G7 Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 145. G7 Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 146. G7 Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 147. G7 Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 148. G7 Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 149. G7 Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 150. NATO Untargeted Metabolomics Market Size, by Group, 2017-2032 (USD Million)
TABLE 151. NATO Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 152. NATO Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 153. NATO Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 154. NATO Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 155. NATO Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 156. NATO Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 157. Global Untargeted Metabolomics Market Size, by Country, 2017-2032 (USD Million)
TABLE 158. United States Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 159. United States Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 160. United States Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 161. United States Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 162. United States Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 163. United States Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 164. United States Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Canada Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 166. Canada Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 167. Canada Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 168. Canada Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 169. Canada Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 170. Canada Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 171. Canada Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 172. Mexico Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 173. Mexico Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 174. Mexico Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 175. Mexico Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 176. Mexico Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 177. Mexico Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 178. Mexico Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 179. Brazil Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 180. Brazil Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 181. Brazil Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 182. Brazil Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 183. Brazil Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 184. Brazil Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 185. Brazil Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 186. United Kingdom Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 187. United Kingdom Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 188. United Kingdom Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 189. United Kingdom Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 190. United Kingdom Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 191. United Kingdom Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 192. United Kingdom Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 193. Germany Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 194. Germany Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 195. Germany Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 196. Germany Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 197. Germany Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 198. Germany Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 199. Germany Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 200. France Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 201. France Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 202. France Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 203. France Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 204. France Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 205. France Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 206. France Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 207. Russia Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 208. Russia Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 209. Russia Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 210. Russia Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 211. Russia Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 212. Russia Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 213. Russia Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. Italy Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 215. Italy Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 216. Italy Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 217. Italy Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 218. Italy Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 219. Italy Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 220. Italy Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 221. Spain Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 222. Spain Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 223. Spain Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 224. Spain Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 225. Spain Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 226. Spain Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 227. Spain Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 228. China Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 229. China Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 230. China Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 231. China Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 232. China Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 233. China Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 234. China Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 235. India Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 236. India Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 237. India Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 238. India Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 239. India Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 240. India Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 241. India Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 242. Japan Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 243. Japan Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 244. Japan Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 245. Japan Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 246. Japan Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 247. Japan Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 248. Japan Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Australia Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 250. Australia Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 251. Australia Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 252. Australia Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 253. Australia Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 254. Australia Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 255. Australia Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 256. South Korea Untargeted Metabolomics Market Size, 2017-2032 (USD Million)
TABLE 257. South Korea Untargeted Metabolomics Market Size, by Component, 2017-2032 (USD Million)
TABLE 258. South Korea Untargeted Metabolomics Market Size, by Instruments, 2017-2032 (USD Million)
TABLE 259. South Korea Untargeted Metabolomics Market Size, by Technology, 2017-2032 (USD Million)
TABLE 260. South Korea Untargeted Metabolomics Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 261. South Korea Untargeted Metabolomics Market Size, by Application, 2017-2032 (USD Million)
TABLE 262. South Korea Untargeted Metabolomics Market Size, by End User, 2017-2032 (USD Million)
TABLE 263. Global Untargeted Metabolomics Market Share, by Key Player, 2025
TABLE 264. Global Untargeted Metabolomics Market, Key Experts

Companies Mentioned

  • Agilent Technologies Inc.
  • Bio-Rad Laboratories, Inc.
  • Biocrates Life Sciences AG
  • Bruker Corporation
  • Danaher Corporation
  • LECO Corporation
  • Metabolon, Inc.
  • PerkinElmer, Inc.
  • Shimadzu Corporation
  • Thermo Fisher Scientific Inc.
  • Waters Corporation

Related Topics

Related Reports

Metabolomics Services Market - Global Forecast 2026-2032 - Product Image

Metabolomics Services Market - Global Forecast 2026-2032

  • Report
  • 192 Pages
  • Global
From
Metabolomics Market - Global Forecast 2026-2032 - Product Image

Metabolomics Market - Global Forecast 2026-2032

  • Report
  • 187 Pages
  • Global
From
Metabolomics Services Market Report 2026 - Product Image

Metabolomics Services Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Metabolomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Metabolomics - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 116 Pages
  • Global
From
Metabolomics Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035) - Product Image

Metabolomics Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook (2026-2035)

  • Report
  • 350 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.